Publication Topic

Pierce JS, Ruestow PS, Finley BL. An updated evaluation of reported chrysotile asbestos no observed adverse effect levels (NOAELs) for lung cancer and mesothelioma. Abstract #2139. Poster presentation at Society of Toxicology 55^th Annual Meeting, New Orleans, LA, 2016.

Benson SM, Batdorf S, Hitchcock KM, Galbraith DA, Finley BL. Asbestos exposure and pharyngeal and laryngeal cancer risk: A fiber-type specific meta-analysis. Abstract #2974. Poster presentation at Society of Toxicology 55^th Annual Meeting, New Orleans, LA, 2016.

Katz AJ, Chia VM, Schoonen WM, Kelsh MA. 2015. Acute lymphoblastic leukemia: An assessment of international incidence, survival, and disease burden. Cancer Causes Control 26(11):1627–1642.

Christian WV, Oliver LD, Paustenbach DJ, Kreider ML, Finley BL. Toxicology based cancer causation analysis of COCR-containing hip implants: A quantitative assessment of genotoxicity and tumorigenicity studies. Poster presentation at Society of Toxicology 54^th Annual Meeting, San Diego, CA, 2015.

Chia VM, O’Malley CD, Danese MD, Lindquist KJ, Gleeson ML, Kelsh MA, et al. 2013. Prevalence and incidence of comorbidities in elderly women with ovarian cancer. Gynecol Oncol 129(2):346–352. doi: 10.1016/j.ygyno.2013.02.014.

Lowe KA, Chia VM, Taylor A, O’Malley C, Kelsh M, Mohamed M, et al. 2013. An international assessment of ovarian cancer incidence and mortality. Gynecol Oncol 130(1): 107–114.

Fryzek J, Pastula S, Jiang X, Garabrant DH. 2013. Childhood cancer incidence in Pennsylvania counties in relation to living in counties with hydraulic fracturing sites. J Occup Environ Med 55(7):796–801.

Alexander D, Weed D, Mink P, Mitchell M. 2012. A weight-of-evidence review of colorectal cancer in pesticide applicators: The agricultural health study and other epidemiologic studies. Int Arch Occup Environ Health 85(7):715–745.

Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, et al. 2012. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 4:283–301.

Mitchell M, Taylor A, Lowe K, Langeberg W, et al. Prevalence of bone metastasis in breast cancer patients and subsequent survival: A systematic and quantitative review of the literature. Presented at the San Antonio Breast Cancer Symposium, San Antonio, TX, December 2011

Lau EC, Mowat FS, Kelsh MA, Legg JC, Engel-Nitz NM, Watson HN, et al. 2011. Use of electronic medical records (EMR) for oncology outcomes research: Assessing the comparability of EMR information to patient registry and health claims data. Clin Epidemiol 3:259–272.

Mitchell M, Taylor A, Lowe K, Langeberg W, et al. Prevalence of bone metastases among breast, lung, and prostate cancer patients. Presented at the 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 2011.

Kelsh MA, Morimoto L, Lau E. Cancer mortality and oil production in the Amazon region of Ecuador. 2009. Int Arch Occup Environ Health 82(3): 381–395.

Kelsh MA, Alexander DD, Kalmes RM, Buffler PA. 2008. Personal use of hair dyes and risk of bladder cancer: A meta-analysis of epidemiologic data. Cancer Causes Control 19(6):549–558.

Mink PJ, Alexander DD, Barraj LM, Kelsh MA, Tsuji JS. 2008. Low-level arsenic exposure in drinking water and bladder cancer: A review and meta-analysis. Regul Toxicol Pharmacol 52(3):299–310.

David RM, Clewell HJ, Gentry PR, Covington TR, Morgott DA, Marino DJ. 2006. Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations. Regul Toxicol Pharmacol 45(1):55–65.

Marino DJ, Clewell HJ, Gentry PR, Covington TR, Hack CE, David RM, Morgott DA. 2006. Revised assessment of cancer risk to dichloromethane: Part I Bayesian PBPK and dose-response modeling in mice. Regul Toxicol Pharmacol 45(1):44–54.